NCT02913196 2026-04-20
Phase I Trial of Apalutamide Plus Abiraterone Acetate, Docetaxel, and Prednisone in Patients With mCRPC
Weill Medical College of Cornell University
Phase 1 Completed
Weill Medical College of Cornell University
Centre hospitalier de l'Université de Montréal (CHUM)
Merck Sharp & Dohme LLC
Canadian Cancer Trials Group
Umeå University